Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study

Creative Commons License

Kocabaş U., Kıvrak T., Yılmaz Ö., Tanık V., Özdemir I., Kaya E., ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.24, no.1, pp.32-40, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.14744/anatoljcardiol.2020.91771
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.32-40
  • Keywords: adherence, chronic heart failure, device therapy, guidelines, pharmacological treatment, outpatients, CARDIAC RESYNCHRONIZATION THERAPY, ESC GUIDELINES, ENALAPRIL, DIAGNOSIS, SURVIVAL
  • Kütahya Health Sciences University Affiliated: Yes


Objective: Despite recommendations from heart failure guidelines on the use of pharmacologic and device therapy in patients with heart failure with reduced ejection fraction (HFrEF), important inconsistencies in guideline adherence persist in practice. The aim of this study was to assess adherence to guideline-directed medical and device therapy for the treatment of patients with chronic HFrEF (left ventricular ejection fraction <= 40%).